Telomir Pharmaceuticals Inc (NASDAQ:TELO) currently has a daily average trading volume of 252.85K but it saw 235925 shares traded in last market. With a market cap of 34.23M USD, the company’s current market price of $1.15 came falling about -2.54 while comparing to the previous closing price of $1.18. In past 52 weeks, the stock remained buoying in the range of price level as high as $8.40 and as low as $1.18. In the recent trading on the day, stock has struck highest price mark of $1.15 while lowest mark touched by it was $1.2.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Rodman & Renshaw which initiated the stock as “Buy” in its note to investors issued on February 21, 2025, recommending a price target of $15 for it.
Over the week, TELO’s stock price is moving -32.35% down while it is -43.63% when we observe its performance for the past one month. Year-to-date it is -72.94% down and over the past year, the stock is showing a downside performance of -72.09%.
The company is expected to be releasing its next quarterly report on 2025-May-14, for which analysts forecasted an EPS of -0.08 while estimate for next year EPS is -0.31.
Currently, Telomir Pharmaceuticals Inc’s total number of outstanding shares is 29.76M with 34.17% of that held by the insiders while 12.53% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -876.77%. Stock’s beta reads -0.93. Its return on asset (ROA) is -626.79% on average.
